【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 17
1.2 List of Figures 25
2 Introduction 28
2.1 Catalyst 28
2.2 Related Reports 29
2.3 Upcoming Related Reports 29
3 Disease Overview 30
3.1 Etiology and Pathophysiology 30
3.1.1 Etiology 30
3.1.2 Pathophysiology 30
3.2 Symptoms 35
3.3 Prognosis 36
3.4 Quality of Life 36
4 Epidemiology 37
4.1 Disease Background 37
4.2 Risk Factors and Comorbidities 37
4.3 Global Trends 39
4.3.1 US 39
4.3.2 5EU 40
4.3.3 Japan 41
4.3.4 Australia 41
4.3.5 China 42
4.3.6 India 42
4.4 Forecast Methodology 42
4.4.1 Sources Used 45
4.4.2 Sources Not Used 49
4.4.3 Forecast Assumptions and Methods – Total Prevalent Cases of RA 50
4.4.4 Forecast Assumptions and Methods – Diagnosed Prevalent Cases of RA 54
4.5 Epidemiological Forecast for RA (2013-2023) 55
4.5.1 Total Prevalent Cases of RA 55
4.5.2 Age-Specific Total Prevalent Cases of RA 57
4.5.3 Sex-Specific Total Prevalent Cases of RA 59
4.5.4 Diagnosed Prevalent Cases of RA 61
4.5.5 Age-Standardized Diagnosed Prevalence of RA 63
4.6 Discussion 65
4.6.1 Epidemiological Forecast Insight 65
4.6.2 Limitations of the Analysis 65
4.6.3 Strengths of the Analysis 66
5 Disease Management 67
5.1 Diagnosis and Treatment Overview 67
5.1.1 Diagnosis 67
5.1.2 Treatment Guidelines 69
5.1.3 Leading Prescribed Drugs for the Treatment of RA 78
5.1.4 Clinical Practice 79
5.2 US 84
5.3 France 88
5.4 Germany 89
5.5 Italy 92
5.6 Spain 94
5.7 UK 95
5.8 Japan 99
5.9 Australia 101
5.10 China 103
5.11 India 105
6 Competitive Assessment 108
6.1 Overview 108
6.2 Product Profiles – Major Brands 109
6.2.1 Enbrel (etanercept) 109
6.2.2 Humira (adalimumab) 116
6.2.3 Remicade (infliximab) 120
6.2.4 Simponi (golimumab) 126
6.2.5 Cimzia (certolizumab pegol) 132
6.2.6 Orencia (abatacept) 136
6.2.7 Actemra/RoActemra (tocilizumab) 142
6.2.8 Rituxan/MabThera (rituximab) 150
6.2.9 Inflectra/Remsima (infliximab biosimilar) 155
6.2.10 Xeljanz (tofacitinib) 158
6.2.11 Iguratimod/T-614 165
6.2.12 Methotrexate (Numerous Brands) 169
6.3 Biosimilars 172
6.3.1 Introduction 172
6.3.2 Hospira’s Inflectra Versus J&J’s Remicade in Key Autoimmune Diseases 174
6.3.3 Biosimilars in the Immunology Community 174
6.3.4 By the Numbers: Biosimilars in Development 175
6.3.5 The Impact of Biosimilars Will be Felt Throughout the Pharmaceutical Industry 179
6.3.6 Uptake of Biosimilars for RA is Expected to Vary by Market 180
6.3.7 Biosimilars’ Forecast 183
6.4 Other Therapies 191
7 Unmet Need and Opportunity 193
7.1 Overview 193
7.2 Development of Cost-Effective Therapies 194
7.2.1 Unmet Need 194
7.2.2 Gap Analysis 195
7.2.3 Opportunity 195
7.3 Biomarkers to Predict Responsiveness to Therapy 196
7.3.1 Unmet Need 196
7.3.2 Gap Analysis 198
7.3.3 Opportunity 198
7.4 Early Diagnosis of RA 199
7.4.1 Unmet Need 199
7.4.2 Gap Analysis 200
7.4.3 Opportunity 201
7.5 Personalized Treatment Approach 202
7.5.1 Unmet Need 202
7.5.2 Gap Analysis 202
7.5.3 Opportunity 204
8 Pipeline Assessment 206
8.1 Overview 206
8.2 Clinical Trial Mapping 206
8.2.1 Clinical Trials by Class 206
8.3 Promising Drugs in Clinical Development 208
8.3.1 Sarilumab 215
8.3.2 Sirukumab 223
8.3.3 Clazakizumab 230
8.3.4 Cosentyx (secukinumab) 236
8.3.5 Tregalizumab 242
8.3.6 Mavrilimumab 248
8.3.7 Denosumab (Prolia/Xgeva) 253
8.3.8 Baricitinib 259
8.3.9 Peficitinib 269
8.3.10 Decernotinib 275
8.3.11 Filgotinib 281
8.3.12 Masitinib 287
8.3.13 RAVAX 294
8.4 Other Drugs in Development 299
9 Current and Future Players 302
9.1 Trends in Corporate Strategy 305
9.2 Company Profiles 306
9.2.1 AbbVie 306
9.2.2 Pfizer 308
9.2.3 Amgen 311
9.2.4 Johnson & Johnson 314
9.2.5 Eli Lilly 316
9.2.6 Bristol-Myers Squibb 318
9.2.7 UCB 320
9.2.8 Roche 321
9.2.9 GlaxoSmithKline 323
9.2.10 Novartis 325
9.2.11 Sanofi 327
9.2.12 AstraZeneca- MedImmune 329
9.2.13 Astellas 331
9.2.14 Vertex 333
9.2.15 Daiichi Sankyo 335
10 Market Outlook 338
10.1 Global Markets 338
10.1.1 Forecast 338
10.1.2 Drivers and Barriers – Global Issues 343
10.2 United States 345
10.2.1 Forecast 345
10.2.2 Key Events 351
10.2.3 Drivers and Barriers 352
10.3 France 354
10.3.1 Forecast 354
10.3.2 Key Events 359
10.3.3 Drivers and Barriers 359
10.4 Germany 362
10.4.1 Forecast 362
10.4.2 Key Events 367
10.4.3 Drivers and Barriers 368
10.5 Italy 371
10.5.1 Forecast 371
10.5.2 Key Events 376
10.5.3 Drivers and Barriers 376
10.6 Spain 378
10.6.1 Forecast 378
10.6.2 Key Events 384
10.6.3 Drivers and Barriers 385
10.7 United Kingdom 387
10.7.1 Forecast 387
10.7.2 Key Events 393
10.7.3 Drivers and Barriers 393
10.8 Japan 396
10.8.1 Forecast 396
10.8.2 Key Events 401
10.8.3 Drivers and Barriers 401
10.9 Australia 404
10.9.1 Forecast 404
10.9.2 Key Events 409
10.9.3 10.9.3 Drivers and Barriers 409
10.10 China 411
10.10.1 Forecast 411
10.10.2 Key Events 416
10.10.3 Drivers and Barriers 416
10.11 India 418
10.11.1 Forecast 418
10.11.2 Key Events 423
10.11.3 Drivers and Barriers 423
11 Appendix 426
11.1 Bibliography 426
11.2 Abbreviations 452
11.3 Methodology 459
11.4 Forecasting Methodology 459
11.4.1 Diagnosed RA Patients 459
11.4.2 Percentage of Drug-Treated Patients 460
11.4.3 Drugs Included in Each Therapeutic Class 460
11.4.4 Launch and Patent Expiry Dates 461
11.4.5 General Pricing Assumptions 462
11.4.6 Individual Drug Assumptions 464
11.4.7 Generic and Biosimilar Erosion 476
11.4.8 Pricing of Pipeline Agents 476
11.5 Primary Research – KOLs Interviewed for This Report 479
11.6 Primary Research – Prescriber Survey 481
11.7 About the Authors 481
11.7.1 Analyst 481
11.7.2 Reviewer 482
11.7.3 Therapy Area Director 482
11.7.4 Epidemiologist 483
11.7.5 Global Head of Healthcare 484
11.8 About GlobalData 485
11.9 Disclaimer 485
【レポート販売概要】
■ タイトル：関節リウマチ（Rheumatoid Arthritis）治療薬の世界市場予測および分析■ 英文：PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023
■ 発行日：2014年12月31日
■ 調査会社：GlobalData
■ 商品コード：GDHC93PIDR
■ 調査対象地域：グローバル
- 世界のデータ品質ツール市場動向（2012-2016）TechNavio's analysts forecast the Global Data Quality Tools market to grow at a CAGR of 16.78 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need to enhance productivity. The Global Data Quality Tools market has also been witnessing the emerging SaaS-based data quality tools. However, the high implementation and product cost could pose a challen …
- アロマ成分の世界市場：合成成分、天然成分Aroma ingredient is a naturally or synthetically produced compound, which is added to food products or cosmetics to impart the desired fragrance. Natural aroma ingredients are extracted from natural sources such as flowers, fruits, wood, and spices, whereas synthetic aroma ingredients are produced from chemical compounds such as esters, aldehydes, alcohols, musk chemicals, and terpenes. Various me …
- 世界のナノ技術市場動向：ナノ材料、ナノツール、ナノデバイスNanotechnology is a growing interdisciplinary technology that is often seen as a new industrial revolution. Nanotechnology is increasingly attracting worldwide attention owing to its wide range of end-uses. As nanotechnology is evolving, so is the scope for its commercial expansion. The wide range of potential products and applications gives nanotechnology its enormous growth prospects. It has bee …
- ナースコールシステムの世界市場予測（～2021年）The nurse call systems market is expected to reach USD 1.75 Billion by 2021 from USD 1.12 Billion in 2016, at a CAGR of 9.3%. This market is segmented based on instruments, technologies, applications, and end users. Aging population and rising prevalence of chronic diseases, new product launches, technological advancements, and increasing healthcare expenditure are some major factors driving the g …
- ソフトウェア・ディファインド・ストレージ（SDS）の世界市場予測（～2021）The global Software-Defined Storage market is expected to grow from USD 4.72 Billion in 2016 to USD 22.56 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 36.7%. The main driving factors for the growth of the market include exponentially growing data volume across enterprises, rise in the “software defined” concept, and need for cost optimization in data management. Among SDS software, …
- 世界の艦艇及び水上戦闘艦艇市場（2014-2024）：地域別分析Synopsis This report offers detailed analysis of the global Naval Vessels and Surface Combatants market over the next ten years, and provides extensive market size forecasts by country and sub sector. It covers the key technological and market trends in the Naval Vessels and Surface Combatants market. Summary "The Global Naval Vessels and Surface Combatants Market 2014-2024 - Country Analysis: Mar …
- 世界の人工膵臓市場2015The Global Artificial Pancreas Industry Report 2015 is a professional and in-depth study on the current state of the Artificial Pancreas industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Artificial Pancreas market analysis is provided for the international markets including development trends, compet …
- 世界のスーパージャンクションMOSFET市場動向及び予測（2013 – 2020）Super junction MOSFET devices currently shares only 2% to 3% of the total power semiconductor device market, which is a $31 billion market. With the popularity and technological innovations in the fabrication and packaging of super junction devices, the scenario in coming five years would be different. The growth of SJ-MOSFET is estimated to be 13.6% from 2013 to 2020. This escalation is developin …
- 高性能計算（HPC）の世界市場：サーバ、ストレージ、ネットワークデバイス、ソフトウェアThe High Performance Computing (HPC) market is estimated to grow from USD 28.08 Billion in 2015 and projected to be of USD 36.62 Billion by 2020, at a high Compound Annual Growth Rate (CAGR) of 5.45% during the forecast period. The scalability of applications, higher processing power, and faster storage solutions is driving the growth of the HPC market. The growth in supercomputing clusters and sc …
- NPK肥料（飼料用及び食品用）の世界市場予測（～2023年）“The NPK fertilizers (food-grade) market is projected to grow at a CAGR of 4.0%.”The NPK fertilizers (food-grade) market is estimated to be valued at USD 2.4 billion in 2018 and is projected to reach USD 2.9 billion by 2023, at a CAGR of 4.0% from 2018 to 2023. The market is driven by a rise in consumption of meat & dairy products and increasing awareness about the quality of food products. Skepti …
- スマートシティ・ITサービスの世界市場2015-2019The market for global smart cities IT services is growing rapidly and Technavios market research analysts predict it will reach a CAGR of more than 18% until 2019. The application of IoT and cloud computing in creating smart grids is a key contributor to the growth of this market. In smart grids, digital technology is used for enabling two-way communication between the utility and its customers. E …
- 遠隔医療の世界市場予測（～2021）：装置、ソフトウェア、サービスThe telehealth market is projected to reach USD 9.35 Billion by 2021 from USD 2.78 Billion in 2016, at a CAGR of 27.5% in the next five years (2016 to 2021). Growth in geriatric population, rising prevalence of chronic diseases, dearth of healthcare professionals worldwide, improvements in telecommunication infrastructure, technological advancements, increasing utilization of connected devices for …
- OTT端末・サービスの世界市場2016-2020About OTT OTT or over-the-top refers to a medium used for delivering diverse media content using the Internet. It is different from video-on-demand where the users need not subscribe to the traditional satellite or cable service such as Comcast and Time Warner Cable. The popularity of OTT services is indirectly affecting the cable companies that prefer to bundle the channel packages and deliver th …
- 世界の脱塩（淡水化）市場動向：Global Desalination Market 2013-2023The Global Desalination Market 2013-2023 is GMR Data’s latest utility report. Primary drivers of the desalination market are increased urbanisation / industrialisation, water scarcity and inadequate or under maintained water infrastructure. The Global Desalination Market 2013-2023 report analyses how this important market will develop over the next ten years. The report quantifies the market in te …
- アメリカの三酸化アンチモン市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of United States and its perspectives on the global market for Antimony oxides. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on Antimony oxides export/import operations in United States. The 2002-2012 period is co …
